FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111255593> ?p ?o ?g. }

• W2111255593 endingPage "3359" @default.
• W2111255593 startingPage "3352" @default.
• W2111255593 abstract "This study analyzed the outcomes of nonrandomized consolidation radiotherapy (RT) given after chemotherapy in the initial treatment of advanced Hodgkin's lymphoma (HL). The results were collected prospectively within a randomized controlled trial of induction chemotherapy.Patients were randomly assigned between doxorubicin, bleomycin, vinblastine, and dacarbazine and one of two prespecified multidrug regimens. At least six cycles of chemotherapy were planned, with up to eight for patients showing slower response. Involved-field RT was recommended for incomplete response to chemotherapy or bulk disease at presentation. The primary outcome measure was progression-free survival (PFS), landmarked from the end of chemotherapy.Among 807 patients randomly assigned, 702 achieved objective response. Postchemotherapy RT for consolidation was reported in 300 (43%). With median follow-up of 6.9 years, 161 PFS events and 83 deaths were reported. Baseline characteristics showed more patients with bulk disease having RT (190 [63%] v 111 [28%]) and only partial response after chemotherapy (150 [50%] v 36 [9%]). Other baseline characteristics were similar. PFS was superior for patients having RT (hazard ratio [HR], 0.43; 95% CI, 0.30 to 0.60) with 5-year PFS 71% without RT, 86% with RT. A similar advantage was seen for overall survival (HR, 0.47; 95% CI, 0.29 to 0.77). There was no evidence of heterogeneity of treatment effect across subgroups.Patients who received consolidation RT apparently had better outcomes, consistently across all prognostic groups which persisted in multivariate analysis. This suggests that RT contributes significantly to the cure rate for advanced HL, although patient selection for combined modality treatment requires better definition in prospective trials." @default.
• W2111255593 created "2016-06-24" @default.
• W2111255593 creator A5007119947 @default.
• W2111255593 creator A5011398209 @default.
• W2111255593 creator A5023188445 @default.
• W2111255593 creator A5024050303 @default.
• W2111255593 creator A5059261043 @default.
• W2111255593 creator A5082102746 @default.
• W2111255593 date "2010-07-10" @default.
• W2111255593 modified "2023-09-26" @default.
• W2111255593 title "Consolidation Radiotherapy in Patients With Advanced Hodgkin's Lymphoma: Survival Data From the UKLG LY09 Randomized Controlled Trial (ISRCTN97144519)" @default.
• W2111255593 cites W1905906989 @default.
• W2111255593 cites W1984997204 @default.
• W2111255593 cites W2010746974 @default.
• W2111255593 cites W2013769287 @default.
• W2111255593 cites W2018925169 @default.
• W2111255593 cites W2045946408 @default.
• W2111255593 cites W2076334524 @default.
• W2111255593 cites W2092192760 @default.
• W2111255593 cites W2107089248 @default.
• W2111255593 cites W2115919161 @default.
• W2111255593 cites W2121605135 @default.
• W2111255593 cites W2121797481 @default.
• W2111255593 cites W2132696402 @default.
• W2111255593 cites W2136962826 @default.
• W2111255593 cites W2142757611 @default.
• W2111255593 cites W2148119102 @default.
• W2111255593 cites W2162848902 @default.
• W2111255593 cites W2163693301 @default.
• W2111255593 doi "https://doi.org/10.1200/jco.2009.26.0323" @default.
• W2111255593 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20498402" @default.
• W2111255593 hasPublicationYear "2010" @default.
• W2111255593 type Work @default.
• W2111255593 sameAs 2111255593 @default.
• W2111255593 citedByCount "72" @default.
• W2111255593 countsByYear W21112555932012 @default.
• W2111255593 countsByYear W21112555932013 @default.
• W2111255593 countsByYear W21112555932014 @default.
• W2111255593 countsByYear W21112555932015 @default.
• W2111255593 countsByYear W21112555932016 @default.
• W2111255593 countsByYear W21112555932017 @default.
• W2111255593 countsByYear W21112555932018 @default.
• W2111255593 countsByYear W21112555932019 @default.
• W2111255593 countsByYear W21112555932020 @default.
• W2111255593 countsByYear W21112555932021 @default.
• W2111255593 countsByYear W21112555932022 @default.
• W2111255593 crossrefType "journal-article" @default.
• W2111255593 hasAuthorship W2111255593A5007119947 @default.
• W2111255593 hasAuthorship W2111255593A5011398209 @default.
• W2111255593 hasAuthorship W2111255593A5023188445 @default.
• W2111255593 hasAuthorship W2111255593A5024050303 @default.
• W2111255593 hasAuthorship W2111255593A5059261043 @default.
• W2111255593 hasAuthorship W2111255593A5082102746 @default.
• W2111255593 hasBestOaLocation W21112555931 @default.
• W2111255593 hasConcept C126322002 @default.
• W2111255593 hasConcept C141071460 @default.
• W2111255593 hasConcept C143998085 @default.
• W2111255593 hasConcept C168563851 @default.
• W2111255593 hasConcept C207103383 @default.
• W2111255593 hasConcept C2776232574 @default.
• W2111255593 hasConcept C2776305933 @default.
• W2111255593 hasConcept C2776694085 @default.
• W2111255593 hasConcept C2776755627 @default.
• W2111255593 hasConcept C2777132456 @default.
• W2111255593 hasConcept C2779338263 @default.
• W2111255593 hasConcept C2779429289 @default.
• W2111255593 hasConcept C2779434656 @default.
• W2111255593 hasConcept C2780964509 @default.
• W2111255593 hasConcept C44249647 @default.
• W2111255593 hasConcept C509974204 @default.
• W2111255593 hasConcept C71924100 @default.
• W2111255593 hasConceptScore W2111255593C126322002 @default.
• W2111255593 hasConceptScore W2111255593C141071460 @default.
• W2111255593 hasConceptScore W2111255593C143998085 @default.
• W2111255593 hasConceptScore W2111255593C168563851 @default.
• W2111255593 hasConceptScore W2111255593C207103383 @default.
• W2111255593 hasConceptScore W2111255593C2776232574 @default.
• W2111255593 hasConceptScore W2111255593C2776305933 @default.
• W2111255593 hasConceptScore W2111255593C2776694085 @default.
• W2111255593 hasConceptScore W2111255593C2776755627 @default.
• W2111255593 hasConceptScore W2111255593C2777132456 @default.
• W2111255593 hasConceptScore W2111255593C2779338263 @default.
• W2111255593 hasConceptScore W2111255593C2779429289 @default.
• W2111255593 hasConceptScore W2111255593C2779434656 @default.
• W2111255593 hasConceptScore W2111255593C2780964509 @default.
• W2111255593 hasConceptScore W2111255593C44249647 @default.
• W2111255593 hasConceptScore W2111255593C509974204 @default.
• W2111255593 hasConceptScore W2111255593C71924100 @default.
• W2111255593 hasIssue "20" @default.
• W2111255593 hasLocation W21112555931 @default.
• W2111255593 hasLocation W21112555932 @default.
• W2111255593 hasOpenAccess W2111255593 @default.
• W2111255593 hasPrimaryLocation W21112555931 @default.
• W2111255593 hasRelatedWork W2019922408 @default.
• W2111255593 hasRelatedWork W2058125934 @default.
• W2111255593 hasRelatedWork W2058793701 @default.
• W2111255593 hasRelatedWork W2077424156 @default.
• W2111255593 hasRelatedWork W2118169390 @default.

• next